Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company
LOS ANGELES, CA, Dec. 03, 2018 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB:ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of non-invasive Electroceutical™ therapies, today announced the company has entered into a non-binding Letter of Intent for a strategic partnership with US Authentic Trading Company (USAT) to act as the exclusive partner to assist with facilitating a…
Read more